Nalaganje...

Risk factors for new-onset diabetes mellitus in patients receiving protease inhibitor therapy

BACKGROUND: Metabolic complications including diabetes mellitus (DM) have been associated with protease inhibitor (PI) therapy. Risk factors for the development of DM are not well-defined. OBJECTIVES: To determine risk factors for the development of new-onset DM in patients initiated on PI therapy....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hughes, Christine A, Cashin, Richard P, Eurich, Dean T, Houston, Stan
Format: Artigo
Jezik:Inglês
Izdano: Pulsus Group Inc 2005
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2095027/
https://ncbi.nlm.nih.gov/pubmed/18159550
Oznake: Označite
Brez oznak, prvi označite!